Cite
MLA Citation
Rakesh Popat et al.. “Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.” Lancet, vol. 3, no. 12, 2016, pp. e572–e580. http://access.bl.uk/ark:/81055/vdc_100039326611.0x000006